Site Management Organizations (SMO) Market
完整報告名稱與涵蓋範圍
Site Management Organizations (SMO) Market Size, Share & Trends Analysis Report, By Service Type (Site Selection, Start-Up and Regulatory Support, Patient Recruitment and Retention, Clinical Trial Conduct and Study Coordination, Data Management, Quality and Compliance Services), By Trial Phase (Phase I, Phase II and Phase III, Phase IV and Real-World Studies), By Therapeutic Area (Oncology, Cardiovascular and Metabolic Diseases, CNS and Neurology, Infectious Diseases and Vaccines, Other Therapeutic Areas), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The site management organizations market covers companies that own, operate or manage networks of clinical research sites and provide site start-up, patient recruitment, study coordination and quality services to sponsors and contract research organisations across trial phases and therapeutic areas. Full-service CROs, individual investigator sites without network management and trial technology vendors are excluded except where they operate site networks.
Growth is driven by sponsor demand for predictable enrollment, faster start-up and consistent data quality, which independent investigator sites struggle to deliver, and by private equity investment that has consolidated hundreds of sites into professionalised networks in the United States. Integrated research organisations embedded in health systems and community practices extend trial access to more diverse populations, while decentralised and hybrid models require sites capable of remote visits and digital data capture. In Japan, China and South Korea, site management organisations remain integral to hospital-based trial conduct, and Asian networks are expanding to serve global sponsors.
North America hosts the largest and most consolidated networks, Japan and Asia Pacific rely on established SMO models, and Europe is seeing early network formation. Competition involves private-equity-backed site networks, health-system-embedded research organisations, Asian SMO leaders and CROs building owned-site capabilities.
The InsightAce study includes revenue forecasts in US$ for all service type, trial phase, therapeutic area and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Site Management Organizations (SMO) Market Snapshot
Chapter 4. Global Site Management Organizations (SMO) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Site Selection, Start-Up and Regulatory Support
5.2.2. Patient Recruitment and Retention
5.2.3. Clinical Trial Conduct and Study Coordination
5.2.4. Data Management, Quality and Compliance Services
Chapter 6. Market Segmentation 2: By Trial Phase Estimates & Trend Analysis
6.1. Trial Phase & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Trial Phase:
6.2.1. Phase I
6.2.2. Phase II and Phase III
6.2.3. Phase IV and Real-World Studies
Chapter 7. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
7.1. Therapeutic Area & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Area:
7.2.1. Oncology
7.2.2. Cardiovascular and Metabolic Diseases
7.2.3. CNS and Neurology
7.2.4. Infectious Diseases and Vaccines
7.2.5. Other Therapeutic Areas
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Sponsors
8.2.2. Contract Research Organizations
8.2.3. Medical Device Companies
Chapter 9. Site Management Organizations (SMO) Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Velocity Clinical Research, Inc.
11.2. Flourish Research
11.3. Headlands Research
11.4. Care Access
11.5. Javara Inc.
11.6. Centricity Research
11.7. Alliance for Multispecialty Research (AMR)
11.8. Elligo Health Research
11.9. EPS Holdings, Inc.
11.10. CMIC Holdings Co., Ltd.
11.11. Tigermed (Hangzhou Tigermed Consulting Co., Ltd.)
11.12. SMO-Pharmina
11.13. Clinical Research Network (CRN)
11.14. Novotech Health Holdings
11.15. ObvioHealth
圖表清單 List of Tables & Figures
Table 1. Global Site Management Organizations (SMO) Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Site Management Organizations (SMO) Market Segmentation Overview
Table 2. Global Site Management Organizations (SMO) Market Revenue Forecast by Trial Phase, 2026-2035 (US$ Mn)
Figure 2. Global Site Management Organizations (SMO) Market Share by Service Type, 2026 & 2035
Table 3. Global Site Management Organizations (SMO) Market Revenue Forecast by Therapeutic Area, 2026-2035 (US$ Mn)
Figure 3. Clinical Research Site Consolidation into Managed Networks by Region, 2020-2035
Table 4. Global Site Management Organizations (SMO) Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Site Management Organizations (SMO) Market Share by Trial Phase, 2026 & 2035
Table 5. North America Site Management Organizations (SMO) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Enrollment and Start-Up Performance: Site Networks Versus Independent Sites
Table 6. Europe Site Management Organizations (SMO) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Site Management Organizations (SMO) Growth Opportunity Analysis
Table 7. Asia Pacific Site Management Organizations (SMO) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Decentralized and Hybrid Trial Capabilities Across Site Management Organizations
Table 8. Latin America Site Management Organizations (SMO) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Site Management Organizations (SMO) Market Participants
Table 9. Middle East & Africa Site Management Organizations (SMO) Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們